Thrombosis
Conference Coverage
Endovascular benefit finally confirmed for basilar artery stroke
The study showed that endovascular therapy for basilar artery occlusion is associated with higher rates of favorable and independent outcomes.
News
FDA limits use of J&J COVID vaccine over blood clot risk
“We recognize that the Janssen COVID-19 vaccine still has a role in the current pandemic response in the United States and across the global...
From the Journals
Traumatic brain injury linked to ‘striking’ risk for CVD, diabetes, brain disorders
Mild and moderate-to-severe TBI is linked to an increased risk for hypertension, stroke, diabetes, as well as neurological and psychiatric...
Conference Coverage
High comorbidity rate seen before osteoarthritis diagnosis
More than 40 medical conditions were positively associated with having a new diagnosis of osteoarthritis in a large, nested case-control study.
Conference Coverage
Anticoagulation not routinely needed after TAVR: ADAPT-TAVR
The ADAPT-TAVR trial showed a numerical reduction in leaflet thrombosis with edoxaban versus dual-antiplatelet therapy, but no reduction in...
Conference Coverage
POISE-3 backs wider use of tranexamic acid in noncardiac surgery
The antifibrinolytic agent significantly reduced the risk for bleeding in a wide array of major noncardiac surgeries, suggesting an expanded role...
Conference Coverage
Hybrid ACC 2022 resurrects the live scientific session
The ACC offers a traditional in-person meeting spanning all of cardiology paired with what could be a lasting legacy of the pandemic, a robust,...
From the Journals
Silver lining emerges for embolic protection in post-TAVR stroke
A database study found that embolic protection during transcatheter aortic valve replacement may improve outcomes, although not the occurrence, of...
From the Journals
Mixed results for cardiologists in stroke thrombectomy
Specialized training and collaboration between specialties, experts say, are essential for interventional cardiologists to achieve results similar...
Conference Coverage
New stroke risk score developed for COVID patients
The user-friendly score represents a step forward but also points to the need to better risk-stratify patients for this complex, expensive, and...
Feature
Novel drug targets raised Lp(a): topline results released
Significant reductions in lipoprotein(a) were sustained out to 150 days in patients without cardiovascular disease in top-line phase 1 results...